Bausch Health Companies Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense
Bausch Health Companies Inc. (BHC) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of $17.00 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Expense Statement › Interest Expense
us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-02-19
- Bausch Health Companies Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2011-09-30 was $900.00K.
- Bausch Health Companies Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2011-06-30 was $900.00K.
- Bausch Health Companies Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $17.00M, a 10.53% decline from fiscal 2023.
- Bausch Health Companies Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $19.00M.
- Bausch Health Companies Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2022 was -$9.00M, a 212.50% decline from fiscal 2021.
- Bausch Health Companies Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2021 was $8.00M.
| Period end | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed |
|---|---|---|---|---|
| 2024-12-31 | $17.00M 10-K · filed 2026-02-19 | |||
| 2023-12-31 | $19.00M 10-K · filed 2025-02-20 | |||
| 2022-12-31 | -$9.00M 10-K · filed 2024-02-22 | |||
| 2021-12-31 | $8.00M 10-K · filed 2023-02-23 | -$8.00M 10-K · filed 2022-02-23 | ||
| 2020-12-31 | $4.00M 8-K · filed 2022-05-11 | |||
| 2019-12-31 | $3.00M 8-K · filed 2021-05-04 | |||
| 2018-12-31 | $3.00M 10-K · filed 2020-02-19 | $1.00M 10-K · filed 2019-02-20 | ||
| 2017-12-31 | $1.00M 10-K · filed 2020-02-19 | $2.00M 10-K · filed 2018-02-28 | ||
| 2016-12-31 | -$7.00M 8-K · filed 2018-08-10 | $7.00M 10-K · filed 2017-03-01 | ||
| 2015-12-31 | $7.00M 10-K · filed 2017-03-01 | |||
| 2014-12-31 | $8.00M 10-K · filed 2016-04-29 | $7.70M 10-K · filed 2015-02-25 | ||
| 2013-12-31 | $5.70M 10-K · filed 2015-02-25 | |||
| 2012-12-31 | $1.30M 10-K · filed 2014-02-28 | |||
| 2011-12-31 | $2.50M 10-K · filed 2013-02-28 | |||
| 2011-09-30 | $900.00K 10-Q · filed 2011-11-04 | $1.80M derived: sum of 2 quarters · filed 2011-11-04 | ||
| 2011-06-30 | $900.00K 10-Q · filed 2011-08-08 | |||
| 2010-12-31 | $3.40M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 |